Regular Strength Pain Relief
NDC Package 63868-217-20
Package Information
Regular Strength Pain Relief is do not take more than directed (see Overdose warning)adults and children 12 years of age and overtake 2 softgels every 4 to 6 hours while symptoms lastdo not take more than 10 softgels in 24 hoursdo not use for more than 10 days unless directed by a doctorchildren 6-11 years of agetake 1 softgel every 4 to 6 hours while symptoms lastdo not take more than 5 softgels in 24 hoursdo not use for more than 5 days unless directed by a doctorchildren under 6 years of ageask a doctor. Marketed by Chain Drug Marketing Association Inc., this product is identified by NDC 63868-217 and is authorized under FDA application part343.
Identification & Billing
- RxCUI: 198436 - acetaminophen 325 MG Oral Capsule
- RxCUI: 198436 - APAP 325 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63868 - Chain Drug Marketing Association Inc.
- 63868-217 - Regular Strength Pain Relief
- 63868-217-20 - 1 BOTTLE in 1 CARTON / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 63868-217 - Regular Strength Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63868-217-20 identifies a specific commercial package of 1 bottle in 1 carton / 20 capsule, liquid filled in 1 bottle of Regular Strength Pain Relief, labeled by Chain Drug Marketing Association Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Marketing Association Inc. on July 13, 2017. The current certification is valid through December 31, 2024.
How is this Chain Drug Marketing Association Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868021720. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.